MCCOY MORETZ, M.D.
It is with great sadness that we announce the passing of “Dr. Mac,” McCoy Moritz, M.D., who died unexpectedly after a brief illness. The entire PhorMed family mourns his loss and extends our deepest sympathies to his family. Dr. Moritz was a brilliant and compassionate physician and medical researcher who brought great dedication to his stewardship of PhorMed as its Chief Executive Officer (CEO) and Chief Medical Officer (CMO).
Ben Chang, President, Chief Financial Officer (CFO), Chairman and Co-Founder, will step in as interim CEO and continues to oversee the day-to-day management of the company. A graduate of East Carolina University with a degree in Economics and International Finance, Ben has over 26 years of pharmaceutical and executive experience. He is also co-inventor of the PhorMed Anti-Virus/COVID-19 patent.
Dr. Sean O’Connell will step up from his seat on the PhorMed Scientific and Medical Advisory Board to serve as Chief Medical Officer (CMO).
Dr. O’Connell received his Ph.D. in Immunology and Molecular Biology from Rutgers University. As a post-doctoral fellow at Rutgers University School of Pharmacy, he worked closely with Dr. Richard Chang, conducting a variety of studies on the action of TPA on promyeloid bone marrow cells.
A seasoned healthcare professional with over 65 peer-reviewed publications, Dr. O’Connell has steered numerous venture capital, pharmaceutical, biotechnology, medical device and tissue processing companies through pre-clinical and clinical development, commercial opportunity assessment, all the way through product and marketing development. Dr. O’Connell met Dr. Moritz as part of a team of surgeons working at Chang’an Hospital in Xi’an, China. Together they developed an autologous stem cell therapy to treat a variety of deleterious skin conditions.
“Dr. Mac contributed immensely to the establishment and growth of PhorMed,” said Ben Chang. “His knowledge, drive, and friendship will be profoundly missed. On behalf of the entire PhorMed family, I would like to reiterate our commitment to seeing his visions realized.”